A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab

Clinical trial NCT06241573 · TERMINATED

Trial details

NCT number: NCT06241573
Sponsor: Boehringer Ingelheim
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hidradenitis Suppurativa (HS)

Start date: 2024-05-08
Primary completion: 2025-04-11
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.